Increased responses to inhaled oxitropium bromide in asthmatic patients with active hepatitis C virus infection

Chest

Volumn 125, Issue 4, 2004, Pages 1368-1371

  Kanazawa, Hiroshi ^a   Hirata, Kazuto ^a   Yoshikawa, Junichi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Airway hyperreactivity; CD8+ T lymphocytes; Cholinergic activity; Muscarinic receptors

Indexed keywords

INTERFERON; METHACHOLINE; OXITROPIUM BROMIDE;

ADULT; AGE DISTRIBUTION; ALLERGIC ASTHMA; ARTICLE; BODY MASS; BRONCHODILATATION; BRONCHUS HYPERREACTIVITY; BRONCHUS REACTIVITY; BRONCHUS TONE; CHOLINERGIC ACTIVITY; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXPIRATORY FLOW RATE; FORCED EXPIRATORY VOLUME; HEPATITIS C; HUMAN; INTERMETHOD COMPARISON; LUNG DIFFUSION CAPACITY; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

EID: 16544383651     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.4.1368     Document Type: Article

References (15)

1. Roffel AF, Elzinga CR, Zaagsma J. Muscarinic M3 receptors mediate contraction of human central and peripheral airway smooth muscle. Pulm Pharmacol 1990; 3:47-51
2. Ayala LE, Ahmed T. Is there loss of protective muscarinic receptor mechanism in asthma? Chest 1989; 96:1285-1291
3. Adamko DJ, Fryer AD, Bochner BS, et al. CD8+ T lymphocytes in viral hyperreactivity and M2 muscarinic receptor dysfunction. Am J Respir Crit Care Med 2003; 167:550-556
4. Koziel MJ, Dudley D, Wong JT, et al. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis. J Immunol 1992; 149:3339-3344
5. Hiroishi K, Kita H, Kojima M, et al. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection. Hepatology 1997; 25:705-712
6. Kanazawa H, Mamoto T, Hirata K, et al. Interferon therapy induces the improvement of lung function by inhaled corticosteroid therapy in asthmatic patients with chronic hepatitis C virus infection: a preliminary study. Chest 2003; 123:600-603
7. Kanazawa H, Hirata K, Yoshikawa J. Accelerated decline of lung function in COPD patients with chronic hepatitis C virus infection: a preliminary study based on small numbers of patients. Chest 2003; 123:596-599
8. Kubo K, Yamaguchi S, Fujimoto K, et al. Bronchoalveolar lavage fluid findings in patients with chronic hepatitis C virus infection. Thorax 1996; 51:312-314
9. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:225-244
10. Nishiguchi S, Kuroki T, Ueda T, et al. Detection of hepatitis C virus antibody in the absence of viral RNA in patients with autoimmune hepatitis. Ann Intern Med 1992; 116:21-25
11. Lukacher A, Braciale V, Braciale T. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J Exp Med 1984; 160:814-826
12. Faul JL, Tormey VJ, Leonard C, et al. Lung immunopathology in cases of sudden asthma death. Eur Respir J 1997; 10:301-307
13. O'Sullivan S, Cormican L, Faul JL, et al. Activated, cytotoxic CD8+ T lymphocytes contribute to the pathology of asthma death. Am J Respir Crit Care Med 2001; 164:560-564
14. Fabbri LM, Romagnoli M, Corbetta L, et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167:418-424
15. Yamada K, Elliott WM, Hayashi S, et al. Latent adenoviral infection modifies the steroid response in allergic lung inflammation. J Allergy Clin Immunol 2000; 106:844-851